Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.

Drescher O, Dewailly E, Diorio C, Ouellet N, Sidi EA, Abdous B, Valera B, Ayotte P.

J Expo Sci Environ Epidemiol. 2014 Nov;24(6):608-14. doi: 10.1038/jes.2013.96. Epub 2014 Jan 22.

PMID:
24448003
2.

Relation between methylmercury exposure and plasma paraoxonase activity in inuit adults from Nunavik.

Ayotte P, Carrier A, Ouellet N, Boiteau V, Abdous B, Sidi EA, Château-Degat ML, Dewailly É.

Environ Health Perspect. 2011 Aug;119(8):1077-83. doi: 10.1289/ehp.1003296. Epub 2011 May 4.

3.

Paraoxonase 1 status in the Thai population.

Phuntuwate W, Suthisisang C, Koanantakul B, Mackness MI, Mackness B.

J Hum Genet. 2005;50(6):293-300. Epub 2005 May 28.

PMID:
15924216
4.

Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.

Kresanov P, Vasankari T, Ahotupa M, Kaikkonen J, Hutri-Kähönen N, Juonala M, Kähönen M, Lehtimäki T, Viikari J, Raitakari OT.

Atherosclerosis. 2015 Aug;241(2):502-6. doi: 10.1016/j.atherosclerosis.2015.06.004. Epub 2015 Jun 6.

PMID:
26091975
5.

Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes.

Li WF, Pan MH, Chung MC, Ho CK, Chuang HY.

Environ Health Perspect. 2006 Aug;114(8):1233-6.

6.

Methylmercury-induced inhibition of paraoxonase-1 (PON1)-implications for cardiovascular risk.

Ginsberg G, Sonawane B, Nath R, Lewandowski P.

J Toxicol Environ Health A. 2014;77(17):1004-23. doi: 10.1080/15287394.2014.919837.

PMID:
25072822
7.

Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.

Kamal M, Fathy MM, Taher E, Hasan M, Tolba M.

Ann Saudi Med. 2011 Sep-Oct;31(5):481-7. doi: 10.4103/0256-4947.84625.

8.

Serum Paraoxonase activity in relation to lipid profile in Age-related Macular Degeneration patients.

AnandBabu K, Bharathidevi SR, Sripriya S, Sen P, Prakash VJ, Bindu A, Viswanathan N, Angayarkanni N.

Exp Eye Res. 2016 Nov;152:100-112. doi: 10.1016/j.exer.2016.09.009. Epub 2016 Sep 28.

PMID:
27693409
9.

Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.

Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, Gill KD.

Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011. Epub 2011 Jul 26.

PMID:
21803130
10.

NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution.

de Aguiar Gonçalves BA, Vasconcelos GM, Thuler LC, Andrade C, Faro A, Pombo-de-Oliveira MS; Brazilian Collaborative Study Group of Infant Acute Leukemia, Emerenciano M, de Camargo B, Bernstain L, Neves CC, Agareno JM, de Carvalho LM, Araújo FN, de Brito NP, Magalhães IQ, Cordoba JC, Pimenta F, Gadelha A, Cartaxo E, Basegio RM, Mnayarji A, Souza MS, Arencibia A, Melaragno R, Cóser VM, Lafayete TC, Koifman S.

Cancer Causes Control. 2012 Nov;23(11):1811-9. doi: 10.1007/s10552-012-0060-5. Epub 2012 Sep 14.

PMID:
22976839
11.

Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms.

Haj Mouhamed D, Ezzaher A, Mechri A, Neffati F, Omezzine A, Bouslama A, Gaha L, Douki W, Najjar MF.

Environ Health Prev Med. 2012 Jul;17(4):316-21. doi: 10.1007/s12199-011-0256-4. Epub 2011 Dec 29.

12.

Human serum paraoxonase gene polymorphisms, Q192R and L55M, are not associated with the risk of cerebral infarction in Chinese Han population.

Huang Q, Liu YH, Yang QD, Xiao B, Ge L, Zhang N, Xia J, Zhang L, Liu ZJ.

Neurol Res. 2006 Jul;28(5):549-54.

PMID:
16808888
13.

Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.

Sirivarasai J, Kaojarern S, Yoovathaworn K, Sura T.

Chem Biol Interact. 2007 Jul 20;168(3):184-92. Epub 2007 Apr 21.

PMID:
17532308
14.

Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.

Bortolasci CC, Vargas HO, Souza-Nogueira A, Barbosa DS, Moreira EG, Nunes SO, Berk M, Dodd S, Maes M.

J Affect Disord. 2014 Apr;159:23-30. doi: 10.1016/j.jad.2014.02.018. Epub 2014 Feb 19.

PMID:
24679385
15.

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.

Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D, Fu X, Shao M, Brennan DM, Ellis SG, Brennan ML, Allayee H, Lusis AJ, Hazen SL.

JAMA. 2008 Mar 19;299(11):1265-76. doi: 10.1001/jama.299.11.1265.

16.

The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.

San Millán JL, Alvarez-Blasco F, Luque-Ramírez M, Botella-Carretero JI, Escobar-Morreale HF.

Hum Reprod. 2006 Dec;21(12):3157-61. Epub 2006 Jul 31.

PMID:
16880229
17.

Association of lead, cadmium and mercury with paraoxonase 1 activity and malondialdehyde in a general population in Southern Brazil.

Almeida Lopes ACB, Urbano MR, Souza-Nogueira A, Oliveira-Paula GH, Michelin AP, Carvalho MFH, Camargo AEI, Peixe TS, Cabrera MAS, Paoliello MMB.

Environ Res. 2017 Jul;156:674-682. doi: 10.1016/j.envres.2017.04.036. Epub 2017 May 5.

PMID:
28477577
18.

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Costa LG, Giordano G, Furlong CE.

Biochem Pharmacol. 2011 Feb 1;81(3):337-44. doi: 10.1016/j.bcp.2010.11.008. Epub 2010 Nov 18. Review.

19.

PON1 polymorphisms are predictors of ability to attain HDL-C goals in statin-treated patients.

de Souza JA, Menin A, Lima LO, Smiderle L, Hutz MH, Van Der Sand CR, Van Der Sand LC, Ferreira ME, Pires RC, Almeida S, Fiegenbaum M.

Clin Biochem. 2015 Nov;48(16-17):1039-44. doi: 10.1016/j.clinbiochem.2015.06.009. Epub 2015 Jun 12.

PMID:
26079344
20.

Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.

Kovács TJ, Harris S, Vas TK, Seres I, Short CD, Wittmann IK, Paragh G, Mackness MI, Mackness B, Durrington PN, Nagy JM, Brenchley PE.

J Nephrol. 2006 Nov-Dec;19(6):732-8.

PMID:
17173245

Supplemental Content

Support Center